MENU
BWAY
AS OF
Feb 4, 01:17 PM (EDT)
Price
$22.02
Change
-$0.92 (-4.01%)
Capitalization
454.39M
35 days until earnings call
Intraday BUY SELL Signals
+Compare
BWAY
Stock ticker: NASDAQ
AS OF
Feb 4, 01:17 PM (EDT)
Price
$22.02
Change
-$0.92 (-4.01%)
Capitalization
454.39M

BWAY BrainsWay Ltd Forecast, Technical & Fundamental Analysis

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders... Show more

BWAY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BWAY with price predictions
Feb 03, 2026

Aroon Indicator for BWAY shows an upward move is likely

BWAY's Aroon Indicator triggered a bullish signal on February 03, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 220 similar instances where the Aroon Indicator showed a similar pattern. In of the 220 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 26, 2026. You may want to consider a long position or call options on BWAY as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BWAY moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where BWAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BWAY turned negative on January 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BWAY broke above its upper Bollinger Band on January 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.398) is normal, around the industry mean (11.546). P/E Ratio (71.453) is within average values for comparable stocks, (38.420). BWAY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). BWAY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (9.560) is also within normal values, averaging (38.937).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
BWAY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BWAY is expected to report earnings to rise 14.00% to 4 cents per share on March 11

BrainsWay Ltd BWAY Stock Earnings Reports
Q4'25
Est.
$0.05
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Est.
$0.02
Q4'24
Beat
by $0.02
The last earnings report on November 11 showed earnings per share of 3 cents, missing the estimate of 5 cents. With 26.22K shares outstanding, the current market capitalization sits at 454.39M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of deep transcranial magnetic stimluation systems, novel, noninvasive medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
19 Hartum Street
Phone
+972 25824030
Employees
106
Web
https://www.brainsway.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIRX15.900.23
+1.47%
Virtus Duff & Phelps Global Infras R6
TCVYX25.340.16
+0.64%
Touchstone Mid Cap Value Y
DCCCX25.500.01
+0.04%
Nomura Small Cap Core C
FOPAX22.04N/A
N/A
Fidelity Advisor Intl Sm Cap Opps A
SROAX13.85-0.17
-1.21%
Calamos Antetokounmpo Sustainable Eqs A

BWAY and Stocks

Correlation & Price change

A.I.dvisor tells us that BWAY and STIM have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BWAY and STIM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-0.56%
STIM - BWAY
32%
Poorly correlated
-4.78%
ISRG - BWAY
31%
Poorly correlated
-1.49%
DCTH - BWAY
31%
Poorly correlated
+0.71%
OM - BWAY
30%
Poorly correlated
-0.80%
QSI - BWAY
28%
Poorly correlated
-2.65%
More

Groups containing BWAY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-0.56%
Medical/Nursing Services
industry (216 stocks)
13%
Poorly correlated
-0.81%
Health Services
industry (410 stocks)
-1%
Poorly correlated
-0.91%